Trial Condition(s):

Magnetic Resonance Imaging, Liver neoplasms

Study to evaluate the diagnostic efficacy of contrast-enhanced MRI with a single intravenous injection of Gd-EOB-DTPA versus contrast-enhanced spiral CT in patients with known or suspected focal malignant liver lesions

Bayer Identifier:

90444

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below.

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
178
Trial Dates
black-arrow
Phase
3
Could I receive a placebo?
No
Products
Eovist/Primovist (Gadoxetate disodium, BAY86-4873)
Accepts Healthy Volunteers
N/A

Where to Participate

Locations
Status
LocationsStatus

Trial Design